Martek Biosciences---- future biotech cash cow! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Martek Biosciences---- future biotech cash cow!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bill small who wrote ()	2/24/1996 3:34:00 AM
From: Asymmetric	of 258

Martek appears in trading range between 30 - 35. Thanks for your earlier reply of about a month ago in another discussion group. Sold my MAXBA for slight profit, and got out of Sepracor likewise. Liked the book on Vertex (Billion Dollar Molecule) so much I bought them on pullback and am showing a slight gain. Apparently Vertex (in partnership with Glaxo) actually has a superior HIV protease inhibitor than Merck, which as you probably know has gotten quite a bit of press. Vertex also has highly thought of management with blue chip backgrounds. Concerning management, do you know anything about quality and background of Martek's management? I just went thru their annual report and other than the fact that 2 of their top officiers came out of a consulting group that did work for Martek there's not a lot of other info. My question is that now that they are shifting to production mode with Formulaid, that's quite of bit of a different challenge from doing R&D.....Earlier news that Merck is renewing agreement regarding their micro algae library of organisms is good news for Martek. Ciao.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next